相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Research progress of dual inhibitors targeting crosstalk between histone epigenetic modulators for cancer therapy
Ying-Chao Duan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives
Robert Jenke et al.
CANCERS (2021)
Hepatocellular Carcinoma: An Overview of the Changing Landscape of Treatment Options
Andreas Koulouris et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2021)
Two-hit wonders: The expanding universe of multitargeting epigenetic agents
Angel R. de Lera et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2020)
Ligand- and structural-based discovery of potential small molecules that target the colchicine site of tubulin for cancer treatment
Qingqing Guo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
Terence C. S. Ho et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Design, synthesis and bioevaluation of novel substituted triazines as potential dual PI3K/mTOR inhibitors
Ting-Ting Wu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Research progress of mTOR inhibitors
Yifan Chen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview
Suvankar Banerjee et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery of Novel Janus Kinase (JAK) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Hematological Malignancies
Xuewu Liang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Metformin Augments Panobinostat's Anti-Bladdere Cancer Activity by Activating AMP-Activated Protein Kinase
Kazuki Okubo et al.
TRANSLATIONAL ONCOLOGY (2019)
HybridMolDB: A Manually Curated Database Dedicated to Hybrid Molecules for Chemical Biology and Drug Discovery
Yecheng Li et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)
Hit Dexter 2.0: Machine-Learning Models for the Prediction of Frequent Hitters
Conrad Stork et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)
Discovery of Novel Dual Histone Deacetylase and Mammalian Target of Rapamycin Target Inhibitors as a Promising Strategy for Cancer Therapy
Yong Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Unmasking the pathological and therapeutic potential of histone deacetylases for liver cancer
Jun Zhao et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2019)
Discovery, biological evaluation, structure-activity relationships and mechanism of action of pyrazolo[3,4-b]pyridin-6-one derivatives as a new class of anticancer agents
Qingqing Guo et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2019)
Identifying a novel anticancer agent with microtubule-stabilizing effects through computational cell-based bioactivity prediction models and bioassays
Yao Luo et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2019)
Next-generation of selective histone deacetylase inhibitors
Feifei Yang et al.
RSC ADVANCES (2019)
Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
Masumeh Sanaei et al.
ADVANCED BIOMEDICAL RESEARCH (2019)
Histone deacetylase inhibitors in hepatocellular carcinoma: A therapeutic perspective
Diamantis Tsilimigras et al.
SURGICAL ONCOLOGY-OXFORD (2018)
Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Based on Ruxolitinib and Vorinostat
Lianbin Yao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Discovery and Development of ATP-Competitive mTOR Inhibitors Using Computational Approaches
Yao Luo et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Downregulation of HDAC6 promotes angiogenesis in hepatocellular carcinoma cells and predicts poor prognosis in liver transplantation patients
Zhen Lv et al.
MOLECULAR CARCINOGENESIS (2016)
eCF309: a potent, selective and cell-permeable mTOR inhibitor
Craig Fraser et al.
MEDCHEMCOMM (2016)
Phase I dose-escalation study of the mTOR inhibitor sirolimus and the HDAC inhibitor vorinostat in patients with advanced malignancy
Haeseong Park et al.
ONCOTARGET (2016)
Discovering new mTOR inhibitors for cancer treatment through virtual screening methods and in vitro assays
Ling Wang et al.
SCIENTIFIC REPORTS (2016)
Molecular Targeted Therapy for Hepatocellular Carcinoma: Present Status and Future Directions
Kyung-Ju Choi et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
Hepatocellular carcinoma: From diagnosis to treatment
Abhijeet Waghray et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Down-regulation of HDAC5 inhibits growth of human hepatocellular carcinoma by induction of apoptosis and cell cycle arrest
Jian Fan et al.
TUMOR BIOLOGY (2014)
Understanding, recognizing, and managing toxicities of targeted anticancer therapies
Grace K. Dy et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Histone deacetylase 3 participates in self-renewal of liver cancer stem cells through histone modification
Chungang Liu et al.
CANCER LETTERS (2013)
The Up-Regulation of Histone Deacetylase 8 Promotes Proliferation and Inhibits Apoptosis in Hepatocellular Carcinoma
Jian Wu et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
Anticancer effects of sodium butyrate on hepatocellular carcinoma cells in vitro
Hong-Gang Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)
Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability
Benjamin E. L. Lauffer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
mTOR kinase structure, mechanism and regulation
Haijuan Yang et al.
NATURE (2013)
Structural insight into the separate roles of inositol tetraphosphate and deacetylase-activating domain in activation of histone deacetylase 3
Mehrnoosh Arrar et al.
PROTEIN SCIENCE (2013)
The pan-deacetylase inhibitor panobinostat induces cell death and synergizes with everolimus in Hodgkin lymphoma cell lines
Manuela Lemoine et al.
BLOOD (2012)
Histone Deacetylases Activate Hepatocyte Growth Factor Signaling by Repressing MicroRNA-449 in Hepatocellular Carcinoma Cells
Reena Buurman et al.
GASTROENTEROLOGY (2012)
The translational landscape of mTOR signalling steers cancer initiation and metastasis
Andrew C. Hsieh et al.
NATURE (2012)
Aberrant Regulation of HDAC2 Mediates Proliferation of Hepatocellular Carcinoma Cells by Deregulating Expression of G1/S Cell Cycle Proteins
Ji Heon Noh et al.
PLOS ONE (2011)
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Jonathan B. Baell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Identification of Histone Deacetylase 3 as a Biomarker for Tumor Recurrence Following Liver Transplantation in HBV-Associated Hepatocellular Carcinoma
Li-Ming Wu et al.
PLOS ONE (2010)
Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
Augusto Villanueva et al.
GASTROENTEROLOGY (2008)
Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases
Beth Apsel et al.
NATURE CHEMICAL BIOLOGY (2008)
mTOR and cancer: insights into a complex relationship
David M. Sabatini
NATURE REVIEWS CANCER (2006)
Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma
TH Hu et al.
CANCER (2003)
分享论文
